Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
Open Access
- 1 June 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9628), 1927-1935
- https://doi.org/10.1016/s0140-6736(08)60602-9
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Metabolic syndrome as a risk factor for coronary heart disease and stroke: An 11-year prospective cohort in Taiwan communityAtherosclerosis, 2007
- Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular DiseaseJournal of the American College of Cardiology, 2007
- An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 DiabetesDiabetes Care, 2007
- The metabolic syndrome: should current criteria influence clinical practice?Current Opinion in Lipidology, 2006
- Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Circulation, 2005
- Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes MellitusCirculation, 2005
- Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening MarkerAmerican Journal of Epidemiology, 2004
- Twenty year follow-up of a cohort based in general practices in 24 British townsJournal of Public Health, 2000
- The design of a prospective study of pravastatin in the elderly at risk (PROSPER)The American Journal of Cardiology, 1999
- British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.BMJ, 1981